Standout Papers

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in C... 2007 2026 2013 2019 820
  1. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer (2008)
    Sooryanarayana Varambally, Qi Cao et al. Science
  2. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression (2011)
    John R. Prensner, Matthew K. Iyer et al. Nature Biotechnology
  3. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer (2014)
    Irfan A. Asangani, Vijaya L. Dommeti et al. Nature
  4. Transcriptome sequencing to detect gene fusions in cancer (2009)
    Christopher A. Maher, Chandan Kumar‐Sinha et al. Nature
  5. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (2007)
    Scott A. Tomlins, Bharathi Laxman et al. Nature

Immediate Impact

10 by Nobel laureates 11 from Science/Nature 95 standout
Sub-graph 1 of 16

Citing Papers

Emerging evidence that the mammalian sperm epigenome serves as a template for embryo development
2023 Standout
Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics
2022 Standout
16 intermediate papers

Works of Xiaojun Jing being referenced

Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
2011 Standout
Transcriptome sequencing to detect gene fusions in cancer
2009 StandoutNature
and 3 more

Author Peers

Author Last Decade Papers Cites
Xiaojun Jing 3351 2149 1109 24 4.3k
Yi-Mi Wu 3037 2351 769 18 4.1k
Irfan A. Asangani 4394 3051 970 50 5.7k
Richard G. A. B. Sewalt 3978 1020 561 19 4.5k
Richard Possemato 3993 1859 870 36 5.4k
Joëlle Tchinda 2645 1349 2306 50 4.6k
Robert J. Lonigro 2420 1515 1538 36 3.9k
Xiaoju Wang 2730 1233 913 45 3.7k
Bharathi Laxman 4463 2595 2350 37 6.3k
Fiona Kaper 2601 2120 729 23 4.1k
Manav Korpal 2189 1716 693 23 3.2k

All Works

Loading papers...

Rankless by CCL
2026